{"schema_version":"1","generated_at":"2026-10-28T11:10:08.006Z","data_as_of":null,"url":"https://www.findmykol.com/kol/priyanka-sharma","json_url":"https://www.findmykol.com/kol/priyanka-sharma/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"priyanka-sharma","name":"Priyanka Sharma","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Kansas Medical Center","institution_url":"https://www.findmykol.com/institution/university-of-kansas-medical-center","city":"Westwood","state":"KS","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1245325562"},"summary":"Priyanka Sharma is an Oncology physician affiliated with University of Kansas Medical Center. ClinicalTrials.gov lists 12 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":12,"shown":3,"withheld":10,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07743632","title":"Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"University of Kansas Medical Center","source_url":"https://clinicaltrials.gov/study/NCT07743632","trial_url":"https://www.findmykol.com/trial/NCT07743632"},{"nct":"NCT05929768","title":"Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer","phase":"PHASE3","status":"RECRUITING","role":"Overall official","sponsor":"SWOG Cancer Research Network","source_url":"https://clinicaltrials.gov/study/NCT05929768","trial_url":"https://www.findmykol.com/trial/NCT05929768"},{"nct":"NCT05645380","title":"Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of Kansas Medical Center","source_url":"https://clinicaltrials.gov/study/NCT05645380","trial_url":"https://www.findmykol.com/trial/NCT05645380"}],"source":"trials"},"payments":{"company_count":15,"program_years":{"first":2021,"last":null},"rows_total":35,"shown":3,"withheld":32,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":10622.07,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245325562"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":6197.81,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245325562"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":4878.31,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245325562"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1245325562","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":62.9,"drugs":[{"name":"Anastrozole","share_pct":100}],"max_beneficiaries":17},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":37.1,"drugs":[{"name":"Verzenio","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":3,"fiscal_years":{"first":2019,"last":2026},"rows_total":14,"shown":3,"withheld":11,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"UG1CA239767","title":"The University of Kansas Cancer Center's- MCA Rural NCORP","fiscal_year":2026,"amount_usd":"1845975","organization":"UNIVERSITY OF KANSAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/UG1CA239767"},{"project":"R21CA307485","title":"Pre-Clinical Evaluation of a Highly Selective SMARCA2 Degrader in Therapy-Resistant Triple-Negative Breast Cancer","fiscal_year":2026,"amount_usd":"398544","organization":"UNIVERSITY OF KANSAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA307485"},{"project":"P30CA168524","title":"Drug Discovery, Delivery and Experimental Therapeutics Program","fiscal_year":2026,"amount_usd":"74126","organization":"UNIVERSITY OF KANSAS MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/P30CA168524"}],"source":"grants"},"contact":{"address_1":"2330 SHAWNEE MISSION PARKWAY","address_2":"SUITE 210, MS 5003","city":"Westwood","state":"KS","zip":"66205","phone":"913-588-6029","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1245325562","source":"identity"},"similar":[{"name":"Mario Castro","slug":"mario-castro","institution":"University of Kansas Medical Center","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/mario-castro","json_url":"https://www.findmykol.com/kol/mario-castro/profile.json"},{"name":"Jeffrey Burns","slug":"jeffrey-burns","institution":"University of Kansas Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/jeffrey-burns","json_url":"https://www.findmykol.com/kol/jeffrey-burns/profile.json"},{"name":"Rajesh Pahwa","slug":"rajesh-pahwa","institution":"University of Kansas Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/rajesh-pahwa","json_url":"https://www.findmykol.com/kol/rajesh-pahwa/profile.json"},{"name":"Mazen Dimachkie","slug":"mazen-dimachkie","institution":"University of Kansas Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/mazen-dimachkie","json_url":"https://www.findmykol.com/kol/mazen-dimachkie/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":10,"payments":32,"funding":11}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2014-05-20","collected_at":"2026-10-27T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}